Growth Metrics

Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.94%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.76%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 16.94%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,488.21%
10 Jazz Pharmaceuticals 14.64 Bn 12.79 Bn 934.80 Mn 17.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.85%
Dec 31, 2025 8.85%
Sep 30, 2025 5.71%
Jun 30, 2025 1.70%
Mar 31, 2025 -1.65%
Dec 31, 2024 6.05%
Sep 30, 2024 8.43%
Jun 30, 2024 6.30%
Mar 31, 2024 5.54%
Dec 31, 2023 12.42%
Sep 30, 2023 7.81%
Jun 30, 2023 6.32%
Mar 31, 2023 9.41%
Dec 31, 2022 5.81%
Sep 30, 2022 16.47%
Jun 30, 2022 27.83%
Mar 31, 2022 23.10%
Dec 31, 2021 23.60%
Sep 30, 2021 24.88%
Jun 30, 2021 19.32%
Mar 31, 2021 13.13%
Dec 31, 2020 12.62%
Sep 30, 2020 10.77%
Jun 30, 2020 6.95%
Mar 31, 2020 6.75%
Dec 31, 2019 21.39%
Sep 30, 2019 14.20%
Jun 30, 2019 7.45%
Mar 31, 2019 15.46%
Dec 31, 2018 9.48%
Sep 30, 2018 16.42%
Jun 30, 2018 27.81%
Mar 31, 2018 16.73%
Dec 31, 2017 13.28%
Sep 30, 2017 8.48%
Jun 30, 2017 1.65%
Mar 31, 2017 12.28%
Dec 31, 2016 14.55%
Sep 30, 2016 11.90%
Jun 30, 2016 14.45%
Mar 31, 2016 11.39%
Dec 31, 2015 5.85%
Sep 30, 2015 11.88%
Jun 30, 2015 20.08%
Mar 31, 2015 30.21%
Sep 30, 2014 34.58%
Jun 30, 2014 42.35%
Mar 31, 2014 27.85%
Sep 30, 2013 45.68%
Jun 30, 2013 63.97%
Mar 31, 2013 78.67%
Dec 31, 2012 98.23%
Sep 30, 2012 107.13%
Jun 30, 2012 84.23%
Mar 31, 2012 94.93%
Dec 31, 2011 -3.85%
Sep 30, 2011 0.00%
Jun 30, 2011 0.00%